HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Issue of Equity
Holding(s) in Company
Brief: Hemogenyx Pharmaceuticals Says DSMB Clears Next Dose Level Of HG-CT-1, Opens Pediatric Recruitment
Half-year Report
Brief: Hemogenyx Pharma Signs LOI To Advance Commercialization Of HG-CT-1 CAR-T Therapy In Estonia
Holding(s) in Company
Invitation to Participate at DCNY Summit
Brief: Made Scientific, Hemogenyx Partner to Advance Hg-Ct-1 CAR-T Therapy for AML
Brief: Hemogenyx Pharma Announces Manufacturing Partnership With Made Scientific
Exercise of Warrants and Issue of Equity
Exercise of Warrants and Issue of Equity
Issue of convertible loan notes
Result of Audit Tender
Placing to Raise £250,000 and Director’s Dealing
Clearance to Proceed with Pediatric Expansion
Placing to Raise £451,250 and Director’s Dealing
Brief: Hemogenyx Pharmaceuticals Says Second Patient Treated With HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation
Second Patient Passes Initial Safety Tests
Brief: Hemogenyx Pharmaceuticals Amends Clinical Protocol For HG-CT-1